Quint Health is a pharmaceutical industry consultancy firm. The mission of Quint Health is to define new innovative products and technologies in the international pharmaceutical market.

Our goal is to provide complete service to our partners.

Quint Health Srl offers a market introduction platform for new products and companies, with specific emphasis, but not limited to the EMEA Region. We specialize in new product development, regulatory affairs and manufacturing with specific emphasis in ophthalmology and dermatology.

Ethis Healthtech, LLC, serves early-stage and emerging firms in the fields of eyecare and mobile/digital healthcare by providing market entry planning and support, fundraising, and strategic communications. Working with both pre-revenue and later-stage firms, the Ethis Healthtech team can draw upon decades of experience in ophthalmology and optometry, technology and commercialization, construction of go-to-market strategies, management of sales teams, and implementation of all aspects of marketing and communications. With a deep network among ophthalmic and digital health multinationals, clinical key opinion leaders, and investors, Ethis Healthtech supports all aspects of its clients’ growth activities.

Phase IV Eyecare Studies is your web-based platform for generating outcomes data to meet European regulatory requirements.


CI Service, LLC, is dedicated to providing professional assistant service for our business partners in the Japanese market.  With vast experience in the pharmaceutical industry (mainly ophthalmology), we can offer you seamless cultural and linguistic access and ensure success in any of your endeavors.